ContractFinancial and Investor Relations Agreement • May 5th, 2020 • Ontario
EX-99.C 4 c22907exv99wc.htm EXHIBIT C Exhibit C Investor /Strategic Partner SECOND AMENDED AND RESTATED FINANCIAL AND INVESTOR RELATIONS AGREEMENT This Agreement is dated effective as of January 28, 2011. BETWEEN: HELIX BIOPHARMA CORP. having an office at 3-305 Industrial Parkway South, Aurora, Ontario, Canada (hereinafter referred to as “Helix” or the “Company”) AND: ACM ALPHA CONSULTING MANAGEMENT EST. having an office at St. Markusgasse 27 a, FL — 9490 Vaduz (hereinafter referred to as “ACM”) WHEREAS Helix previously retained ACM to provide Helix with investor and financial advisory services in Europe, by execution of the Financial and Investor Relations Agreement dated as of January 25, 2010 (hereinafter referred to as the “Original Agreement”); WHEREAS the Original Agreement was amended and restated (as so amended and restated, the “First Restated Agreement”) pursuant to an Amended and Restated Financial and Investor Relations Agreement effective June 28, 2010; WHEREAS the First R
AMENDED AND RESTATED FINANCIAL AND INVESTOR RELATIONS AGREEMENT This Agreement is dated effective as of June 28, 2010.Financial and Investor Relations Agreement • August 17th, 2010 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario
WHEREAS Helix previously retained ACM to provide Helix with investor and financial advisory services in Europe, by execution of the Financial and Investor Relations Agreement dated as of January 25, 2010 (hereinafter referred to as the “Original Agreement”); and
